China Shineway Pharmaceutical Group Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CSWYF research report →
About the company
China Shineway Pharmaceutical Group Limited functions as an investment holding company, primarily engaged in the development, manufacturing, and commercialization of traditional Chinese medicines. Its operations span across the People's Republic of China and Hong Kong. The company's diverse product portfolio includes contemporary Chinese medicines, supplied in formats such as soft capsules, granules, and injections, alongside traditional Chinese medicine (TCM) Formula Granules.
- CEO
- Zhenjiang Li
- IPO
- 2020
- Employees
- 3,220
- HQ
- Shijiazhuang, CN
Price Chart
- Market Cap
- $758.42M
- P/E
- 5.17
- P/S
- 1.57
- P/B
- 0.61
- EV/EBITDA
- -2.33
- Div Yield
- 8.05%
- Gross Margin
- 72.28%
- Op Margin
- 21.75%
- Net Margin
- 30.30%
- ROE
- 11.97%
- ROIC
- 5.93%
- Revenue
- $3.14B · -17.01%
- Net Income
- $949.95M · 13.08%
- EPS
- $1.26 · 13.51%
- Op Income
- $717.80M
- FCF YoY
- 18.36%
- 52W High
- $1.00
- 52W Low
- $0.93
- 50D MA
- $1.00
- 200D MA
- $1.00
- Beta
- 0.71
- Avg Volume
- 57.6
Get TickerSpark's AI analysis on CSWYF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CSWYF coverage
Recent articles, reports, and earnings notes.
No research on CSWYF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CSWYF report →Similar companies
Peers in the same neighborhood.